Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
BPC-157 has been in its first human clinical trial since 2025 (Phase 1, USA)
PubMed laboratory research record [PMID: 6174456] PubMed record related to this compound for laboratory literature review
Key findings include: Enhanced load-to-failure measurements in healing tendons compared to controls Improved collagen organization and fiber alignment at injury sites Accelerated tendon-to-bone healing in ligament injury models Dose-dependent effects with optimal responses observed at 10 mcg/kg in rodent studies TB-500 research demonstrated enhanced cellular migration and actin polymerization in tendon fibroblasts, while GHK-Cu studies showed increased collagen synthesis and improved tissue remodeling
Through systematic fractionation of human albumin, Pickart and colleagues isolated a small peptide responsible for the difference, eventually identifying it as a three-amino-acid sequence glycine, histidine, and lysine with an unusually strong affinity for binding copper(II) ions
US$ 22.42
US$ 20.02
US$ 20.97
US$ 23.32
US$ 20.85
)
